(Q43707889)

English

Effect of caffeine on intestinal absorption of ergotamine in man.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Effect of caffeine on intestinal absorption of ergotamine in man. (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

R Schmidt

1

1 reference

Europe PubMed Central

26 November 2017

A Fanchamps

2

1 reference

Europe PubMed Central

26 November 2017

publication date

1 January 1974

1 reference

Europe PubMed Central

26 November 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

26 November 2017

7

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

213-216

1 reference

Europe PubMed Central

26 November 2017

https://scigraph.springernature.com/pub.10.1007/bf00560383

0 references

Controlled clinical trial of ergotamine tartrate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of headache; with particular reference to the use of cafergone for the relief of attacks

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Craniovascular studies in headache; a report and analysis of pulse volume tracings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in treatment of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the migraine attack

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complexes of ergot alkaloids and derivatives. I. The interaction of caffeine with ergotamine tartrate in aqueous solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further observations in craniovascular studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TREATMENT OF MIGRAINE-Results with Dihydroergocornine Methanesulfonate (DHO-180) and Other Ergot Derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recent work on pathogenesis and treatment of headache]

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the symptomatic treatment of chronic vascular headache with cafergone (ergotamine tartrate and caffeine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of headache

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hereditary cephalalgia

1 reference

https://pubmed.ncbi.nlm.nih.gov/4851611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00560383

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43707889&oldid=2102724083"